indomethacin & phosphatidylcholine (PL 4500)
/ PLx Pharma
- LARVOL DELTA
Home
Next
Prev
1 to 3
Of
3
Go to page
1
December 02, 2024
Multifunctional Indomethacin Conjugates for the Development of Nanosystems Targeting Cancer Treatment.
(PubMed, Int J Nanomedicine)
- "While free IND was active at a concentration of 270.5 μM, in the form of the phospholipid conjugate (IND-OA-PC), it inhibited the growth of cancer cells at 67.5 μM and after conjugate encapsulation (IND-OA-PC-NLC) it was effective at only 10.3 μM. Our study revealed that the conjugation of NSAID with phosphatidylcholine and its combination with nanotechnology techniques create opportunities to repurpose well-known drugs from this group for new therapeutic applications."
Journal • Breast Cancer • Gastrointestinal Disorder • HER2 Breast Cancer • HER2 Positive Breast Cancer • Hormone Receptor Breast Cancer • Oncology • Solid Tumor • Triple Negative Breast Cancer • HER-2
March 12, 2017
"Not using much Cangrelor. If IV antiplt is needed, I go with bolus 2b3a or bolus + short infusion."
- SVRaoMD
Biosimilar
February 17, 2020
Polymer/lipid interplay in altering in vitro supersaturation and plasma concentration of a model poorly soluble drug.
(PubMed, Eur J Pharm Sci)
- "Solution viscosity, solid-state properties and morphology of ASDs were related to the results. This study revealed fundamental mechanisms of PVP/PC mixture effect on IND supersaturation and oral bioavailability, demonstrating that polymer/lipid mixture could be used as a promising carrier to alter supersaturation profile and oral bioavailability of SDDS products."
Journal • Preclinical
1 to 3
Of
3
Go to page
1